Vaccines, Blood & Biologics

Federal Register Notice: Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments

In the Federal Register of October 30, 2015 (80 FR 68455), we are clarifying the following information as follows:

On page 66845, under DATES, the third sentence is revised to read:  Persons seeking to attend (including FDA employees) or to present at the public hearing must register by January 8, 2016.

On page 66847, under section IV. Attendance and Registration, the third sentence is revised to read:  Individuals who wish to attend (including FDA employees) or present at the public hearing must register by sending an email to  CBERPublicEvents@fda.hhs.gov on or before January 8, 2016, and provide complete contact information, including name, title, affiliation, address, email and phone number. 

The SUPPLEMENTARY section and DATES section of this Federal Register Notice are being revised for consistency and to clarify that both those attending (including FDA employees) and those wishing to present must register as provided in the notice.
 

Page Last Updated: 12/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.